Close

RXRX Financial Facts

See Full Income Statement

See Full Balance Sheet

Recursion Pharmaceuticals, Inc. (RXRX) Earnings

  |   Expand Research on RXRX
Next EPS Date 5/7/24 EPS Growth Rate -23.5%
Average EPS % Beat Rate +7.4% Revenue Growth Rate -6.8%
Average % Move 1-Wk after EPS +5.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/7/24 Q124 N/A-$0.42 N/A N/A$11.3M N/A N/A N/A
2/27/24 Q423 -$0.42-$0.46 +$0.04$10.89M$19.9M N/A Details
11/9/23 Q323 -$0.43-$0.39 -$0.04$10.53M$11.24M N/A Details
8/10/23 Q223 N/A-$0.38 N/A N/A$11.87M N/A N/A N/A
5/8/23 Q123 -$0.34-$0.35 +$0.01$12.13M$12.97M N/A Details
3/22/23 Q422 N/A-$0.29 N/A N/A$28.03M N/A N/A N/A
11/8/22 Q322 -$0.28-$0.39 +$0.11$2.5M$6.96M N/A Details
8/9/22 Q222 -$1.30-$0.37 -$0.93$186K$5.33M N/A Details